|
HMGN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.681200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.541200E-01 |
| Normal-vs-Stage2 |
6.761200E-01 |
| Normal-vs-Stage3 |
1.732000E-02 |
| Normal-vs-Stage4 |
1.434160E-01 |
| Stage1-vs-Stage2 |
5.498000E-01 |
| Stage1-vs-Stage3 |
4.807900E-04 |
| Stage1-vs-Stage4 |
3.801500E-02 |
| Stage2-vs-Stage3 |
1.989230E-01 |
| Stage2-vs-Stage4 |
5.083400E-01 |
| Stage3-vs-Stage4 |
3.691600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.957200E-01 |
| Normal-vs-AfricanAmerican |
2.971200E-01 |
| Normal-vs-Asian |
9.744600E-01 |
| Caucasian-vs-AfricanAmerican |
6.213400E-01 |
| Caucasian-vs-Asian |
7.870800E-01 |
| AfricanAmerican-vs-Asian |
6.203600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.079200E-01 |
| Normal-vs-Female |
8.745200E-01 |
| Male-vs-Female |
1.188590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.660000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.755600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.535800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.418600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.568030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.603400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.480400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.727800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.847600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.825400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.678800E-01 |
| Normal-vs-Grade 2 |
4.515400E-01 |
| Normal-vs-Grade 3 |
1.020170E-01 |
| Normal-vs-Grade 4 |
3.583200E-04 |
| Grade 1-vs-Grade 2 |
4.572200E-01 |
| Grade 1-vs-Grade 3 |
6.485600E-02 |
| Grade 1-vs-Grade 4 |
2.140500E-03 |
| Grade 2-vs-Grade 3 |
9.592000E-04 |
| Grade 2-vs-Grade 4 |
6.42369999970249E-07 |
| Grade 3-vs-Grade 4 |
2.782400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.903800E-02 |
| Normal-vs-ccB subtype |
6.002600E-04 |
| ccA subtype-vs-ccB subtype |
1.29896093881143E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.282600E-01 |
| Normal-vs-N1 |
8.434100E-02 |
| N0-vs-N1 |
1.463030E-01 |
|
|
